Metabolic basis of the NADPH-independent disulfide reductase system in mouse liver

小鼠肝脏中不依赖 NADPH 的二硫键还原酶系统的代谢基础

• 批准号: 10005545
• 负责人: Gina Marie DeNicola
• 金额: $ 46.39万
• 依托单位: MONTANA STATE UNIVERSITY - BOZEMAN
• 依托单位国家: 美国
• 财政年份: 2019
• 资助国家: 美国
• 起止时间: 2019-09-12 至 2020-09-11
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/10005545
• 关键词: Active Sites; Adenosine; Anabolism; Biliary; Biology; Bypass; Carbon; Catabolism; Cells; Coenzyme A; Consumption; Creatine; Cultured Cells; Cysteine; DNA; DNA Methylation; Dependence; Disease; Disulfides; Enzymes; Excretory function; Folic Acid; Future; Generations; Glutamates; Glutathione; Glutathione Disulfide; Glutathione Reductase; Glycine; Health; Hepatic; Hepatocyte; Homeostasis; Inflammatory; Investigation; Knowledge; Lead; Lecithin; Lipids; Liver; Malignant Neoplasms; Mammalian Cell; Metabolic; Metabolic Pathway; Metabolism; Methionine; Methylation; Methyltransferase; Microbe; Modeling; Mus; NADP; Natural regeneration; Nerve Degeneration; Normal Cell; Nutrient; Organoids; Outcome; Oxidants; Oxidation-Reduction; Oxidative Stress; Oxidoreductase; Pathogenicity; Pathway interactions; Patients; Peripheral; Physiological; Positioning Attribute; Predisposition; Process; Production; Proteins; RNA; Reaction; Regulation; Resources; Role; Route; S-Adenosylhomocysteine; Serine; Source; Stress; Sulfur; Sulfur Amino Acids; Sulfur Metabolism Pathway; System; Taurine; Testing; Tissues; Toxin; Translations; Vision; Work; amino acid metabolism; base; carbon skeleton; clinical application; combat; histone methylation; liver metabolism; metabolomics; methyl group; mouse model; novel therapeutic intervention; oxidation; oxidative damage; pathogen; prevent; reaction rate; regenerative; response; therapeutic target; thioredoxin reductase; thioredoxin reductase 1; uptake

What is known: Disulfide reduction-fueled enzymes s!upport homeostasis and combat oxidative damage that contributes to neurodegeneration, inflammatory diseases, and cancer. NADPH provides the reducing power for most anabolic and cytoprotective reduction reactions, yet only two enzymes can use NADPH to reduce cytosolic disulfides: thioredoxin reductase-1 (TrxR1) and glutathione reductase (Gsr) 1. Both TrxR1 and Gsr have active sites that are dominantly inhibited by electrophilic toxins and oxidants 2, 3. In Co-PI Schmidt's lab, mice with TrxR1/Gsr-null livers uncovered unexpected robustness in the disulfide reductase systems, including an NADPH-independent pathway that uses catabolism of methionine (Met) to sustain redox homeostasis 4. Importantly, this pathway is also thought to sustain normal cells under oxidative or electrophilic stress 5. Met and Cys are the 2 sulfur (S)-amino acids found in proteins, but S-containing molecules synthesized from Met or Cys, including S-adenosyl-Met (SAM), glutathione (GSH), CoA, and others, are also important in redox, detox, energetics, biosynthesis, regulation, and other processes. Co-PI DeNicola has been studying the roles of altered S-amino acid metabolism in sustaining some cancers 6. These studies are revealing how some cancers use altered S-amino acid redox metabolism, which could uncover targetable cancer-specific susceptibilities. Unresolved questions: It remains unknown how other metabolic activities, including those that directly utilize Met or Cys, as well as more peripheral systems that either (i) supply resources to these pathways; (ii) depend upon these pathways; or (iii) might, in some conditions, compete with these pathways for substrates, are realigned to help cells survive stress. We hypothesize that conversion to Met-dependence involves realignment of diverse metabolic pathways. A better understanding of these processes will uncover processes that can be therapeutically targeted to either specifically increase the robustness of critical cells under oxidative or toxic stress, or specifically increase the vulnerability of pathogenic cells in cancer or inflammatory diseases. What is proposed: In this collaborative project, we will define the metabolic pathway realignments that occur when hepatocytes switch from NADPH-dependent to -independent disulfide reduction. We propose 3 Specific Aims: Aim 1, Define how NADPH- versus Met-fueled disulfide reductase homeostasis influences S-metabolism prioritization. Aim 2, Define how re-wiring of serine metabolism supports Met-fueled disulfide reductase homeostasis. Aim 3, Test whether Met-dependent survival increases the activity and dependence on liver methyltransferases. Anticipated outcomes, value: This project will help us understand how global shifts in hepatic metabolism occurs in response to severe oxidative or electrophilic stress in liver, and how this helps sustain health.

已知：二硫化物还原驱动的酶S！支持体内平衡和对抗氧化损伤 会导致神经退化、炎症性疾病和癌症。NADPH为 大多数合成代谢和细胞保护还原反应，但只有两种酶能使用NADPH还原 胞质二硫化物：硫氧还蛋白还原酶-1(TrxR1)和谷胱甘肽还原酶(GSR)1。TrxR1和GSR 具有主要被亲电毒素和氧化剂2、3抑制的活性部位。在Co-Pi Schmidt的实验室中， TrxR1/GSR阴性肝脏的小鼠在二硫化物还原酶系统中发现了意想不到的健壮性，包括 NADPH非依赖性途径，利用蛋氨酸(Met)的分解代谢来维持氧化还原动态平衡。 重要的是，这一途径也被认为在氧化或亲电应激下维持正常细胞。 和半胱氨酸是蛋白质中发现的2个含硫(S)氨基酸，但含有S的分子是从蛋氨酸或蛋白质中合成的 半胱氨酸，包括S-腺苷蛋氨酸(SAM)、谷胱甘肽(GSH)、辅酶A等，在氧化还原、脱毒、 能量学、生物合成、调节和其他过程。联席派·德尼古拉一直在研究 S-氨基酸代谢改变在某些癌症中的持续6.这些研究揭示了一些癌症是如何 利用改变的S-氨基酸氧化还原代谢，可以揭示靶向癌症特异性易感性。 悬而未决的问题：尚不清楚其他代谢活动，包括那些直接利用 MET或Cys，以及更多的外围系统，它们或者(I)向这些通路提供资源；(Ii)依赖于 在这些途径上；或(Iii)在某些情况下，可能与这些途径竞争底物， 重新排列以帮助细胞在压力下生存。我们假设，转换为Met依赖涉及到 重新调整不同的代谢途径。对这些过程的更好理解将揭示过程 它可以在治疗上作为靶点，专门增加关键细胞在氧化作用下的健壮性 或毒性应激，或特别增加癌症或炎症性疾病中致病细胞的脆弱性。 建议：在这个合作项目中，我们将定义发生的代谢途径重新排列 当肝细胞从依赖NADPH的还原转变为非依赖的二硫化物还原时。我们提出3个具体的建议 目的：目标1，明确NADPH与蛋氨酸所致的二硫键还原酶稳态对S代谢的影响 确定优先顺序。目的2，确定丝氨酸代谢的重新连接如何支持蛋氨酸燃料的二硫化物还原酶 动态平衡。目的3，测试蛋氨酸依赖存活是否增加了对肝脏的活性和依赖性 甲基转移酶。 预期结果，价值：这个项目将帮助我们了解全球肝脏代谢的变化 在肝脏中发生严重的氧化或亲电应激，以及这如何帮助维持健康。